HK1130434A1 - Treatment and prevention of excessive scarring - Google Patents

Treatment and prevention of excessive scarring

Info

Publication number
HK1130434A1
HK1130434A1 HK09109463.0A HK09109463A HK1130434A1 HK 1130434 A1 HK1130434 A1 HK 1130434A1 HK 09109463 A HK09109463 A HK 09109463A HK 1130434 A1 HK1130434 A1 HK 1130434A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
excessive scarring
scarring
excessive
Prior art date
Application number
HK09109463.0A
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Elisabeth Lenestour
Jay Bua
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06291239A external-priority patent/EP1891945A1/en
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of HK1130434A1 publication Critical patent/HK1130434A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09109463.0A 2006-07-31 2009-10-14 Treatment and prevention of excessive scarring HK1130434A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83416306P 2006-07-31 2006-07-31
EP06291239A EP1891945A1 (en) 2006-07-31 2006-07-31 Treatment and prevention of excessive scarring
PCT/EP2007/057838 WO2008015190A2 (en) 2006-07-31 2007-07-30 Treatment and prevention of excessive scarring

Publications (1)

Publication Number Publication Date
HK1130434A1 true HK1130434A1 (en) 2009-12-31

Family

ID=38829603

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109463.0A HK1130434A1 (en) 2006-07-31 2009-10-14 Treatment and prevention of excessive scarring

Country Status (6)

Country Link
EP (1) EP2046310B1 (ja)
JP (1) JP5189093B2 (ja)
AU (1) AU2007280440B2 (ja)
CA (1) CA2659344C (ja)
HK (1) HK1130434A1 (ja)
WO (1) WO2008015190A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834927B2 (en) 2010-04-01 2014-09-16 Pharmanest Ab Thermogelling anaesthetic compositions
US20140348873A1 (en) * 2013-05-22 2014-11-27 Professional Compounding Centers Of America Urea-Silicone Gel for Hyperkeratosis Treatment
CN114984301B (zh) * 2022-05-30 2023-03-17 浙江大学 一种促进创面无瘢痕愈合的抗菌敷料及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63502508A (ja) * 1986-01-31 1988-09-22 ホイットビ−・リサ−チ・インコ−ポレ−テッド １−置換アザシクロアルカンより成る組成物とその用途
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
IT1283042B1 (it) * 1996-05-21 1998-04-07 Condea Augusta Spa Composizioni cosmetiche deodoranti e/o antitraspiranti
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP2003095983A (ja) * 2001-09-21 2003-04-03 Lion Corp 皮膚外用剤組成物
JP2003252798A (ja) * 2002-02-28 2003-09-10 Shiseido Co Ltd 抗菌ゲル製剤
US20050079228A1 (en) * 2003-05-30 2005-04-14 Ashish Jaiswal Clear, stable topical compositions of clarithromycin and processes for their preparation
GB0312428D0 (en) * 2003-05-30 2003-07-09 Medtrade Products Ltd Scar management composition
PT1631275E (pt) * 2003-06-09 2008-08-04 Ascend Therapeutics Inc Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno
EP1684761A1 (en) * 2003-11-19 2006-08-02 Acrux DDS Pty Ltd Method and composition for treatment or prophylaxis of amyloidosis disorders
WO2006002050A1 (en) * 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use

Also Published As

Publication number Publication date
EP2046310A2 (en) 2009-04-15
CA2659344A1 (en) 2008-02-07
WO2008015190A8 (en) 2008-06-12
AU2007280440B2 (en) 2013-03-21
WO2008015190A2 (en) 2008-02-07
WO2008015190A3 (en) 2008-03-20
JP5189093B2 (ja) 2013-04-24
AU2007280440A1 (en) 2008-02-07
EP2046310B1 (en) 2011-11-02
JP2009545559A (ja) 2009-12-24
CA2659344C (en) 2015-03-17

Similar Documents

Publication Publication Date Title
EP2007284A4 (en) DEVICES AND METHOD FOR TISSUE TREATMENT
IL194820A0 (en) Devices and methods for treatment of tissue
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
GB0610867D0 (en) Treatment of pain
EP2088952A4 (en) METHODS AND DEVICES FOR PROCESSING FABRICS
HK1134679A1 (zh) 用於治療感染的組合物和方法
EP2043727A4 (en) DEVICES AND METHOD FOR THE TREATMENT OF ADIPOSITAS
EP2249854A4 (en) IMPROVED TREATMENT AND PROPHYLAXIS
ZA200904806B (en) Prevention and treatment of sub-clinical pcvd
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
IL193748A0 (en) Treatment of pain
ZA200908100B (en) Treatment and prevention of influenza
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2035024A4 (en) TREATMENT AND PREVENTION OF PANCREATIC CANCER WITH DELTA TOCOTRIENOL
EP2001488A4 (en) PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES
IL196411A0 (en) Anti-cocaine compositions and treatment
EP2083848A4 (en) PROCEDURE FOR TREATMENT AND PROPHYLAXIS
EP2096927A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF TREATING WITH CAPSIANOSIDE COMPOUNDS
GB2441094B (en) Methods for treatment and prevention of infection
GB0610868D0 (en) Treatment of pain
HK1130434A1 (en) Treatment and prevention of excessive scarring
IL196983A0 (en) Treatment and prevention of intestinal fibrosis
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
IL194798A0 (en) Treatment of melanoma